Dover has entered into a definitive agreement to amass Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Image: dizain/Adobe Stock.
เกจวัดแรงดันน้ำ10บาร์ will broaden Dover’s biopharma single-use production offering, which already contains Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with facilities in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in revenue in the course of the full 12 months 2022.
When the deal closes, Malema will turn into part of the PSG business unit within Dover’s Pumps & Process Solutions section.
“We see an amazing long-term growth alternative in the bioprocessing trade pushed by a strong and rising pipeline of effective novel biologic medicine, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the rising adoption of more environment friendly single-use manufacturing processes supports a strong outlook for our choices of single-use elements to end-customers. We imagine that pairing Malema’s expertise with our existing portfolio of single-use pumps for biopharma processing will tremendously enhance the accuracy and value proposition of our options to our prospects.”
“We are methodically building out our biopharma platform through proactive capability additions, new product growth, and opportunistic acquisitions of highly-attractive area of interest part technologies,” said Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing know-how and additional strengthens our sensor portfolio with new proprietary know-how. In addition to enticing biopharma functions, we expect sturdy development in the semiconductor space on the capacity growth and re-shoring tailwinds.”
Share